~~<i id='D248C1C67E'><strike id='D248C1C67E'><tt id='D248C1C67E'><pre id='D248C1C67E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：hotspot 2025-09-28 00:52:51 - browse：941

Calling Bullshit course University of Washington — Screenshot via callingbullshit.org

Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

The class website and colorful syllabus went online last month and almost instantly went viral.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： HHS secretary Becerra pressed on Change HealthCare cyberattack

focus

knowledge

hotspot

entertainment

focus

explore

DavidL.Ryan/TheBostonGlobeStewardHealthCare’sMassachusettshospitalsareonthebrinkoffinancialdisaster.

WSS

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

iTeos Therapeutics debuts first data on TIGIT

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Childbirth

Biohaven protein

Ebola: Gilead Sciences antiviral shows promise as new treatment

Wikipedia

knowledge

focus

Anesthesiologist group: stop taking Ozempic before surgery

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Medical leaders decry Supreme Court decision on affirmative action

How many hemophilia patients actually want gene therapy?

Anesthesiologist group: stop taking Ozempic before surgery

Addiction doctors spar with methadone clinics over legislation

Guidelines to prevent youth baseball injuries need more muscle

David Sabatini, ex

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

knowledge

How to save health care price transparency rules

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

HHS secretary Becerra pressed on Change HealthCare cyberattack

Startling documents reveal new facets of Sacklers' opioid empire

hotspot

entertainment

focus

explore